Lung cancer and radiofrequency ablation

被引:80
作者
Rose, Steven C.
Thistlethwaite, Patricia A.
Sewell, Patrick E.
Vance, Ralph B.
机构
[1] Univ Calif San Diego, Dept Radiol, Med Ctr, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Surg, Med Ctr, San Diego, CA 92103 USA
[3] Univ Mississippi, Med Ctr, Dept Radiol, Jackson, MS 39216 USA
[4] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA
关键词
NSCLC = non-small-cell lung cancer; PET = positron emission tomography; RF = rachofrequency;
D O I
10.1097/01.RVI.0000222707.44902.66
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Radiofrequency (RF) ablation is a recently developed technique for image-guided local destruction of selected tumors. Because the lung is a common site for cancer and usually has substantial functional reserve, RF ablation of lung cancers is an attractive option for minimally invasive treatment. The primary goal of the present review is to describe the natural history, staging systems, and conventional therapies for primary and secondary treatment of lung cancer, as well as the results of RF ablation in animal models and in humans for pulmonary applications, to clarify the appropriate role and limitations of this technology. The secondary goals are to review the principles of how RF works and to describe RF ablation techniques to familiarize interventionalists who may consider incorporating this technology into their practice and inform diagnostic radiologists of expected imaging findings and clinicians of their patients' anticipated courses and outcomes.
引用
收藏
页码:927 / 951
页数:25
相关论文
共 142 条
[91]  
MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S
[92]   Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits [J].
Nomori, H ;
Imazu, Y ;
Watanabe, K ;
Ohtsuka, T ;
Naruke, T ;
Kobayashi, T ;
Suemasu, K .
CHEST, 2005, 127 (03) :973-977
[93]   TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
OKEN, MM ;
CREECH, RH ;
TORMEY, DC ;
HORTON, J ;
DAVIS, TE ;
MCFADDEN, ET ;
CARBONE, PP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655
[94]  
Pass Harvey I., 1997, P2536
[95]   Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases [J].
Pastorino, U ;
Buyse, M ;
Friedel, G ;
Ginsberg, RJ ;
Girard, P ;
Goldstraw, P ;
Johnston, M ;
McCormack, P ;
Pass, H ;
Putnam, JB ;
Cerrina, J ;
Chapelier, A ;
Dartevelle, P ;
Baldeyrou, P ;
Grunenwald, D ;
Bulzebruck, H ;
Schirren, J ;
VogtMoykopf, I ;
Toomes, H ;
vanGeel, AN ;
Cappello, M ;
Rocmans, P ;
Pietraszek, A ;
Sklodowska, M ;
Andreani, S ;
Incarbone, M ;
Ravasi, G ;
Tavecchio, L ;
Ambrogi, V ;
Ricci, C ;
Mineo, T ;
Maggi, G ;
Briccoli, A ;
Gelmini, R ;
Heidari, A ;
Guernelli, N ;
Beltrami, V ;
Bains, MS ;
Burt, ME ;
Martini, N ;
McCormack, PM ;
Rusch, VW ;
Roth, J ;
Holmes, C ;
Temeck, B ;
Marchand, P .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (01) :37-47
[96]   Analysis of tissue and arterial blood temperatures in the resting human forearm (Reprinted from Journal of Applied Physiology, vol 1, pg 93-122, 1948) [J].
Pennes, HH .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (01) :5-34
[97]   American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003 [J].
Pfister, DG ;
Johnson, DH ;
Azzoli, CG ;
Sause, W ;
Smith, TJ ;
Baker, S ;
Olak, J ;
Stover, D ;
Strawn, JR ;
Turrisi, AT ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :330-353
[98]   Lung cancer • 5:: State of the art radiotherapy for lung cancer [J].
Price, A .
THORAX, 2003, 58 (05) :447-452
[99]   Creation of radiofrequency lesions in a porcine model: Correlation with sonography, CT, and histopathology [J].
Raman, SS ;
Lu, DSK ;
Vodopich, DJ ;
Sayre, J ;
Lassman, C .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (05) :1253-1258
[100]   Treatment of stage IIIA non-small cell lung cancer [J].
Robinson, LA ;
Wagner, H ;
Ruckdeschel, JC .
CHEST, 2003, 123 (01) :202S-220S